Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 43 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMITsai, V.; Macia, L.; Feinle-Bisset, C.; Manandhar, R.; Astrup, A.; Raben, A.; Lorenzen, J.; Schmidt, P.; Wiklund, F.; Pedersen, N.; Campbell, L.; Kriketos, A.; Xu, A.; Zhou, P.; Jia, W.; Curmi, P.; Angstmann, C.; Lee-Ng, K.; Zhang, H.; Marquis, C.; et al.; Young, M.
2015Influence of light exposure during early life on the age of onset of bipolar disorderBauer, M.; Glenn, T.; Alda, M.; Andreassen, O.; Angelopoulos, E.; Ardau, R.; Baethge, C.; Bauer, R.; Baune, B.; Bellivier, F.; Belmaker, R.; Berk, M.; Bjella, T.; Bossini, L.; Bersudsky, Y.; Wo Cheung, E.; Conell, J.; Del Zompo, M.; Dodd, S.; Etain, B.; et al.
2015A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinomaPal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2011Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver SurgeryKoch, M.; Garden, J.; Padbury, R.; Rahbari, N.; Adam, R.; Capussotti, L.; Sheung, T.; Yokoyama, Y.; Crawford, M.; Makuuchi, M.; Christophi, C.; Banting, S.; Brooke-Smith, M.; Usatoff, V.; Nagino, M.; Maddern, G.; Hugh, T.; Vauthey, J.; Greig, P.; Rees, M.; et al.
2009Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisFellstrom, B.; Jardine, A.; Schmeider, R.; Holdaas, H.; Bannister, K.; Beutler, J.; Chae, D.; Chevaile, A.; Cobbe, S.; Gronhagen-Riska, C.; De Lima, J.; Lins, R.; Mayer, G.; McMahon, A.; Parving, H.; Samuelsson, O.; Sonkodi, S.; Suleymanlar, G.; Tsakiris, D.; Tesar, V.; et al.
2008Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialDavis, S.; Donnan, G.; Parsons, M.; Levi, C.; Butcher, K.; Peeters, A.; Barber, P.; Bladin, C.; De Silva, D.; Byrnes, G.; Chalk, J.; Fink, J.; Kimber, T.; Schultz, D.; Hand, P.; Frayne, J.; Hankey, G.; Muir, K.; Gerraty, R.; Tress, B.; et al.
2003Fluoropolymer coated Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicentre trialRobinson, B.; Fletcher, J.; Richardson, A.; Tomlinson, P.; Bell, R.; Fisher, C.; Condous, M.; Ventura, R.; Scott, A.; Stary, D.; Allen, R.; Lippey, E.; Appleberg, M.; Chao, A.; Fitridge, R.; Frydman, G.; Hazelton, S.; King, B.; Middleton, P.; Pai, P.; et al.
2016Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypesMachiela, M.; Lan, Q.; Slager, S.; Vermeulen, R.; Teras, L.; Camp, N.; Cerhan, J.; Spinelli, J.; Wang, S.; Nieters, A.; Vijai, J.; Yeager, M.; Wang, Z.; Ghesquières, H.; McKay, J.; Conde, L.; de Bakker, P.; Cox, D.; Burdett, L.; Monnereau, A.; et al.
2012A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Lim, S.; Vos, T.; Flaxman, A.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; AlMazroa, M.; Amann, M.; Anderson, H.; Andrews, K.; Aryee, M.; Atkinson, C.; Bacchus, L.; Bahalim, A.; Balakrishnan, K.; Balmes, J.; Barker-Collo, S.; Baxter, A.; Bell, M.; Blore, J.; et al.